SHAREHOLDER ALERT: Investigation on Behalf of Northwest Biotherapeutics, Inc. Investors Announced by Law Offices of Howard G....
June 19 2014 - 3:32PM
Business Wire
Law Offices of Howard G. Smith announces that it is
investigating potential claims on behalf of investors of Northwest
Biotherapeutics, Inc. (“Northwest Biotherapeutics” or the
“Company”) (NASDAQ:NWBO). The investigation concerns possible
violations of federal securities laws and focuses on certain
statements issued by Northwest Biotherapeutics concerning the
Company’s operations and prospects.
Northwest Biotherapeutics is a biotechnology company engaged in
the discovery and development of immunotherapy products to treat
cancers in the United States and internationally. The Company is
involved in the development of DCVax, a platform technology that
uses activated dendritic cells to mobilize a patient’s own immune
system to attack cancer. The investigation is related to an article
published June 19, 2014, by TheStreet.com, alleging that the MD
Anderson Cancer Center “issued a stern rebuke to Northwest
Biotherapeutics for making promotional, unjustified claims about
results from an ongoing clinical trial of an experimental cancer
vaccine known as DCVax-Direct.” The article further alleges that
the vice president of clinical research at the MD Anderson Cancer
Center stated that claims in certain of the Company’s press
releases concerning the DCVax-Direct clinical trials are
preliminary and unconfirmed. Following this news, the price of
Northwest Biotherapeutics shares dropped nearly 20 percent in
intraday trading on June 19, 2014.
If you purchased Northwest Biotherapeutics securities, if you
have information or would like to learn more about these claims, or
if you have any questions concerning this announcement or your
rights or interests with respect to these matters, please contact
Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070
Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone
at (215) 638-4847, Toll Free at (888) 638-4847, or by email to
howardsmith@howardsmithlaw.com, or visit our website at
www.howardsmithlaw.com.
Law Offices of Howard G. SmithHoward G. Smith, Esquire(215)
638-4847(888)
638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Apr 2024 to May 2024
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From May 2023 to May 2024